Dr Reddy's shares: Semaglutide woes to trigger EPS cuts; Should you buy, sell or hold?
Dr Reddy's shares remain under pressure after its semaglutide production halt. Here's what leading brokerages expect for earnings, target prices and recovery.
Read the full article3d agoen
You might also wanna read
CBI arrests MD of Bengaluru-based PSU for accepting ₹5 lakh bribe
businesstoday.in·8h ago
NEET UG 2026 final answer key released: Here's how to check your score
businesstoday.in·8h ago
BT Explainer | When banks can seize property from loan defaulters: RBI's new rules decoded
businesstoday.in·8h ago
JSW MG Motor India to launch EV, plug-in hybrid on new multi-powertrain platform
businesstoday.in·8h ago
SBI Funds Management IPO subscribed 41.66x; here's what drove nearly ₹3 lakh crore demand
businesstoday.in·9h ago
HCLTech to acquire Guardian India; nearly 2,000 employees to join the IT giant
businesstoday.in·9h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.